Øivind Foss
Chief Tech/Sci/R&D Officer chez ULTIMOVACS ASA
Profil
Øivind Foss is currently the Head of Clinical Operations at Ultimovacs ASA. Prior to this, he worked as the Director of Clinical Project Management at Smerud Medical Research International AS and as the Director of Clinical Operations at Pharmalink Oncology AS.
Foss holds a doctorate degree from the Norwegian University of Science & Technology.
Postes actifs de Øivind Foss
| Sociétés | Poste | Début |
|---|---|---|
| ULTIMOVACS ASA | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Øivind Foss
| Sociétés | Poste | Fin |
|---|---|---|
| Pharmalink Oncology AS | Chief Tech/Sci/R&D Officer | - |
Smerud Medical Research International AS
 Smerud Medical Research International AS BiotechnologyHealth Technology Smerud Medical Research International AS operates as drug development company and contract research organization. The firm specializes in proof-of-concept clinical trials and pivotal regulatory trials. It offers clinical operations, biostatistics, data management, regulatory affairs, medical writing, and consultation. The company was founded by Knut Terje Smerud in 1993 and is headquartered in Oslo, Norway. | Corporate Officer/Principal | - |
Formation de Øivind Foss
| Norwegian University of Science & Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ULTIMOVACS ASA | Health Technology |
| Entreprise privées | 2 |
|---|---|
Smerud Medical Research International AS
Smerud Medical Research International AS BiotechnologyHealth Technology Smerud Medical Research International AS operates as drug development company and contract research organization. The firm specializes in proof-of-concept clinical trials and pivotal regulatory trials. It offers clinical operations, biostatistics, data management, regulatory affairs, medical writing, and consultation. The company was founded by Knut Terje Smerud in 1993 and is headquartered in Oslo, Norway. | Health Technology |
| Pharmalink Oncology AS |
